The use of vesicular carriers has recently emerged as a feasible method for minimizing the obstructive effects of the stratum corneum. The use of transferosomes, also known as ultradeformable lipids or elastic liposomes, in cutaneous distribution has attracted a lot of attention. They are generally used to treat a range of chronic skin disorders, but they may also be utilised to guarantee patient compliance via concentrated and controlled distribution. These self-assembled nanocarriers may adjust their pore size to that of the stratum corneum. Edge activators (specific surfactants), phospholipids, buffering agents, and other substances are found in transferosomes. Due to the activity of edge activators and their concentration, constructed vesicles have the requisite flexibility. Drug solubilization, efficient drug loading, and therapeutic molecule permeability may all be improved by elastic liposomes. As nanocarriers, transferosomes have improved reflectivity and provide a diverse platform for effective transdermal applications. These one-of-a-kind nanocarriers also have exceptional elasticity and penetration. These systems are thought to be safe, with effective delivery routes for pharmaceutically and aesthetically active chemical moieties. Recent scientific results highlighting the need for ultradeformable liposomes have revealed that medication penetration is constant and effective. This book contains up-to-date research as well as in-depth updates on crucial issues and the usage of future transferosomes with enhanced bioavailability profiles.